Pharmaceuticals Financial News

affordable for the consumer. A panel formed to address regulatory challenges with regard to nutraceuticals is looking at ways to regulate their prices, people in the know told ET. At present nutraceuticals come under the ambit of Food Safety and Standards Authority of India (FSSAI) and there are no such price regulations. «Nutraceuticals are generally sold as over the counter (OTC) products. It has been seen that pharma companies are marketing them at high prices,» said an official aware of the line of thought in the government. «For example, in the case of vitamins, the companies are using active pharmaceutical ingredients (API) for manufacturing a medicine. They then mix it with another ingredient to make it into a nutraceutical and sell it at exorbitant prices,» he added. At present, there are no rules and regulations to regulate the prices of nutraceuticals. «But this is going to get changed,» another person said. Senior officials from the ministry of health and family welfare, department of pharmaceuticals are (DoP), ministry of food processing industries, FSSAI, the Drugs Controller General of India (DCGI), director general of the Indian Council of Medical Research (ICMR) and the director general of health services are actively discussing the issue and will soon come out with measures to regulate the prices.

monsoon boosted sales of drugs for respiratory, anti-infective, anti-malaria and gastrointestinal therapies in June. According to market researcher Pharmarack, these therapies saw a double-digit growth last month compared to June 2023. «Among the top therapies, anti-infectives and respiratory have shown a relatively stronger volume growth for the month of June,» said Sheetal Sapale, VP, commercial at Pharmarack.

Sun Pharma, a pharmaceutical company, unveiled its #SecondBirthDate 2.0 campaign on National Doctors’ Day. This year’s initiative features Bollywood actor, Sushmita Sen, who has joined the movement to express her gratitude to doctors. 

cybersecurity professionals, especially at the leadership level, are more in demand than before. Organisations have started to consider cyber as a key enterprise-wide risk that can not only pose financial losses but also tarnish reputations, destroy customer trust, and even threaten public safety, says Anand Venkatraman, Partner, Deloitte India. The stakes are higher in today’s interconnected digital landscape, and this calls for robust cyber defences and risk management strategies. There is a clear surge in demand for cyber insurance so that organisations can offset or transfer some financial damage from this risk. The areas of demand

Dr. Reddy's Laboratories with a target price of Rs 6500. The current market price of Dr. Reddy's Laboratories Ltd. is Rs 6429.85. Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 106802.89 Crore) operating in Pharmaceuticals sector.

electoral bonds to make political donations potentially face questions from tax authorities on deductions that were made on these contributions with the Supreme Court having scrapped the scheme in February. A few companies have already received notices for deductions claimed for political contributions made through electoral bonds, people familiar with the development told ET.

The IPOs of Emcure Pharmaceuticals, in which shark tank fame Namita Thapar is the Executive Director and Bansal Wire will open for subscription next week in the mainboard segment, while Ambey Laboratories is the sole SME issue.

Medicamen Organics listed with a premium of 305.44% on the NSE SME platform on Friday. The stock debuted at Rs 137.85, compared with an issue price of Rs 34 Ahead of the listing, the company's shares were trading with a premium of Rs 50 in the unlisted market.

₹137.85 apiece on NSE SME, a premium of 305.44% to the issue price of ₹34 per share.Medicamen Organics IPO listing was stronger than the market expectations. Medicamen Organics IPO GMP today ahead of the listing was ₹70 per share, indicating a listing premium of more than 205%.The initial public offering (IPO) of pharmaceutical dosages manufacturer Medicamen Organics Ltd was launched on June 21 and the bidding ended on June 25.

₹960 to ₹1,008 per equity share of the face value of ₹10. The Emcure Pharmaceuticals IPO date of subscription is scheduled for Wednesday, July 3, and will end on Friday, July 5.

Walgreens has shared a rather disturbing announcement, claiming that due to many of their US stores currently struggling, they have taken a call to close down some of them. According to ABC News, one out of four Walgreens stores in the US are underperforming amid stiff contest from competing retail chains like Target.

Raghuvanshi on Thursday said the risk-based inspections based on revised Schedule M of the Drugs and Cosmetics Act will begin from July 1. «We will make a framework (for the risk-based inspection). We will switch the checklist and the questions which we look at when we go there (for audits),» Raghuvanshi said on the sidelines of an Indian Pharmaceutical Alliance (IPA) event. Raghuvanshi said there would be surprise inspections, which would take 3-4 days.

A fire has broken out on top of a building housing Denmark’s taxation ministry, leading to the evacuation of the offices and adjacent houses

Neueon Towers Ltd.(up 4.83%), KEC International Ltd.(up 3.50%), NTPC Ltd.(up 3.32%), JSW Energy Ltd.(up 3.27%), GE Power India Ltd.(up 2.33%), SJVN Ltd.(up 2.08%), Adani Green Energy Ltd.(up 1.93%), Tata Power Company Ltd.(up 1.68%), Power Grid Corporation of India Ltd.(up 1.49%) and Suzlon Energy Ltd.(up 0.99%) stood among the top gainers.

Top Gainers: Whirlpool Of India (up 8.37%), Mazagon Dock Shipbuilders (up 8.19%), Suven Pharmaceuticals (up 7.62%), Caplin Point Laboratories (up 7.60%), Macrotech Developers (up 7.48%)Top Losers: Clara Industries (down 6.99%), Indiabulls Real Estate (down 6.36%), Deepak Fertilisers & Petrochemicals Corporation (down 5.74%), GR Infraprojects (down 5.34%), Equitas Small Finance Bank (down 4.91%)Top Gainers: Mazagon Dock Shipbuilders (up 8.22%), Whirlpool Of India (up 8.02%), Suven Pharmaceuticals (up 7.97%), Manappuram Finance (up 7.49%), Macrotech Developers (up 7.22%)Top Losers: Deepak Fertilisers & Petrochemicals Corporation (down 6.02%), Archean Chemical Industries (down 4.92%), Equitas Small Finance Bank (down 4.90%), Fertilizers & Chemicals Travan (down 4.76%), Sunteck Realty (down 4.64%).Sources:- [BSE Top Gainers](https://www.livemint.com/market/bse-top-gainers)- [BSE Top Losers](https://www.livemint.com/market/bse-top-losers)- [NSE Top Gainers](https://www.livemint.com/market/nse-top-gainers)- [NSE Top Losers](https://www.livemint.com/market/nse-top-losers)Milestone Alert! Livemint tops charts as the fastest growing news website in the world

MUMBAI : India has long relied on global giants for medical devices to equip a healthcare network burdened by a lack of doctors, expensive treatments, and inadequate technology. Now, domestic medtech firms are taking the fight to their international peers, attracting interest from top-tier global investors and pharmaceutical giants. According to Indian government estimates, India is the fourth-largest market for medical devices in Asia.

CHICAGO—Tech entrepreneur Rishi Shah was sentenced to seven-and-a-half years in prison Wednesday for his part in what prosecutors called a billion-dollar fraud scheme centered on video advertisements in doctors’ offices. Federal Judge Thomas Durkin said Shah, former chief executive and co-founder of startup Outcome Health, had undermined the integrity of the markets. “The only deterrence to white-collar crime or any kind of crime is jail," he said.

Dr. Reddy's Laboratories Ltd.(up 2.08 per cent), Gland Pharma Ltd.(up 0.91 per cent), Lupin Ltd.(up 0.28 per cent), Alkem Laboratories Ltd.(up 0.16 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 0.11 per cent) were among the top gainers.

Ponni Sugars(Erode)Ltd.(up 0.71%), Avadh Sugar & Energy Ltd.(up 0.34%) and KM Sugar Mills Ltd.(up 0.24%) were among the top gainers.

The NSE Nifty index traded 98.3 points up at 23967.1, while BSE Sensex was up 340.19 points at 79014.44 as of 10:29AM(IST)on June 27.

Centre fixes price of drugs for diabetes, hypertension, multivitaminsThe primary task of the committee is to strike a balance between pricing and availability of essential medicines, while offering incentives to the industry to foster growth and exports. Prices of drugs in India are regulated as per provisions of Drugs (Prices Control) Order, 2013, by the NPPA, under the aegis of the Department of Pharmaceuticals (DoP), that fixes the ceiling price of scheduled medicines.